. >> to discuss the rising cost of generic drugs is pharmacist robert frankel. >> what's behind the spike >> well, it can be a variety of issues. production problems, raw material shortages, the fda has increased scrutiny on some manufacturing plants especially in india where over 40% of the prescription drugs in america are manufactured. and there's also a consolidation in the marketplace where different generic manufacturers are buying each other out and thereby causing fewer manufacturers to make any given drug. >> on that point i know there are a lot of finger pointing. who's to whraim -- who's to blame? >> it's the fda a little bit. you have to point the fingers directly at them. all of these factors can increase drug prices by five, ten, 20% and that's somewhat understandable when competition is decreased. but there is no explanation for a drug that goes up 1,000, even 8,000%. >> what's the best practice for controlling these costs? >> that's a great question and that's what the hearing was all about. there should be an agency somewhere in the united states, that oversees this. righ